Electronic Patient-Reported Outcomes (ePROS) Market Dynamics, Recent Developments, and Strategic Insights by 2031

The electronic patient-reported outcomes (ePROS) market size is projected to reach US$ 2,868.00 million by 2031 from US$ 843.77 million in 2023. The market is expected to register a CAGR of 16.5% during 2023–2031. The integration of artificial intelligence and machine learning with ePROS platforms is likely to act as a future trend in the market.

Electronic Patient-Reported Outcomes (ePROS) Market Analysis

The electronic patient-reported outcomes (ePROS) market is mainly driven by continuous efforts made by pharmaceutical and biotechnology sectors and medical device companies for product innovations. Other factors contributing to the market expansion include the globalization of clinical trials, rapid advancements in associated technologies, and an increase in demand for CROs for conducting clinical trials. Furthermore, conferences such as Global Clinical Trials Connect 2022 offer a platform to companies in this marketplace. The platform helps companies get acquainted with advancements in clinical trials and clinical research.

Electronic Patient-Reported Outcomes (ePROS) Market Overview

Market players are taking various strategic initiatives such as product launches, product approvals, and collaborations, which are further expected to support the market growth. For instance, in June 2024, Evidation launched MigraineSmart, which is a health engagement experience and symptom tracking program on the Evidation app that harnesses survey data, electronic patient-reported outcomes (ePROs), wearable data, and evidence-based content to make it possible for individuals to better understand and manage their migraines. Therefore, an increase in digital health technologies, a surge in demand for patient-centered care, and a rise in strategic initiatives by market players are expected to fuel the growth of the electronic patient-reported outcomes (ePROs) market in the coming years.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Electronic Patient-Reported Outcomes (ePROS) Market: Strategic Insights

Electronic Patient-Reported Outcomes (ePROS) Market

• 
  CAGR (2023 - 2031)

  16.5%
• Market Size 2023
  US$ 843.77 Million
• Market Size 2031
  US$ 2,868.00 Million

Market Dynamics

GROWTH DRIVERS

• Emerging Applications of Electronic Patient-Reported Outcomes (ePROS)

FUTURE TRENDS

• The integration of artificial intelligence and machine learning with ePROS platforms

OPPORTUNITIES

• Rising Adoption of Telehealth and Remote Monitoring

Key Players

• OpenClinica LLC
• Buddy Healthcare Ltd Oy
• Castor
• Medable Inc
• Assistek
• Signant Health
• Crucial Data Solutions
• Curebase
• Y Prime LLC
• Clinical Ink Inc

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Delivery Mode

• Cloud Based
• On-Premises

Application

• Oncology
• Respiratory
• Others

End User

• Contract Research Organizations [CROs]
• Pharmaceutical Companies
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Electronic Patient-Reported Outcomes (ePROS) Market Drivers and Opportunities

Emerging Applications of Electronic Patient-Reported Outcomes (ePROS)

The emerging applications of electronic patient-reported outcomes (ePRO) drive the market. The new uses of ePRO systems in decentralized clinical trials, remote patient monitoring, and other areas are stimulating innovation and extending the use of patient-reported outcomes in various healthcare, research, and clinical settings. The adoption of ePRO systems is driven by decentralized clinical trials (DCTs) growth. Patients can participate in DCTs remotely from the comfort of their homes, and ePRO tools are widely used for collecting patient-reported data immediately. The transition to virtual trials improves patient recruitment and retention; lowers the need for in-person visits; and increases trial efficiency of various diseases, including rare diseases, across geographically dispersed populations. In addition, the players are making strategic developments to meet the customers' needs. For instance, in June 2023, uMotif, a clinical trial technology company, and Syneos Health, an integrated biopharmaceutical solution company, announced a strategic partnership. By developing a more effective, end-to-end digital platform with electronic solid clinical outcome assessment (eCOA) and electronic patient-reported outcomes (ePRO) capabilities—this partnership helped accelerate clinical trials and expedite the delivery of new therapies to patients.

ePRO systems are being used to monitor acute conditions such as post-operative recovery and chronic conditions, including diabetes and hypertension, as healthcare increasingly moves toward telemedicine and remote patient monitoring (RPM). To help healthcare providers make regular interventions and changes to care plans, patients can report symptoms, medication adherence, and treatment responses from the comfort of their own homes. This approach lowers the rate of hospital readmissions, enhances chronic illness management, and improves patient satisfaction by offering ongoing, individualized care without requiring frequent in-person visits.

The adoption of ePRO systems is propelled by the growing use of wearables, including smartwatches, fitness trackers, and Internet of Things (IoT) devices in the healthcare industry. Predictive healthcare interventions can be made possible by combining objective data from wearables with subjective patient-reported outcomes. This results in better condition monitoring and proactive condition management. Pharmaceutical companies are utilizing ePRO systems to monitor adverse events in real-world settings, helping them gain traction in pharmacovigilance and post-market surveillance, thereby ensuring long-term drug safety and efficacy while adhering to regulatory requirements.

Rising Adoption of Telehealth and Remote Monitoring to Offer Opportunity for Market Growth

The market for electronically reported patient outcomes (ePROs) is expected to experience lucrative opportunities with the rising adoption of telehealth and remote monitoring for clinical trials during the forecast period. Patients in remote or underserved areas can report real-time information from the comfort of their homes owing to telehealth and remote monitoring solutions, which increase the accessibility of patient data. Health data can be continuously transmitted via remote monitoring devices, such as wearables and linked health systems. When coupled with ePRO systems, medical professionals receive detailed information regarding a patient's condition in real time, enabling more precise and regular interventions. For example, Vivalink's integrated acute remote patient monitoring solution provides continuous and real-time monitoring of patient vitals, including live ECG, as well as information about vitals and biometrics, EPRO/ECOA/surveys, centralized data services, remote data collection, and patient adherence. The efficacy of ePRO systems is expanded by telehealth and remote monitoring developments, establishing them as a crucial element of patient-centered care.

Electronic Patient-Reported Outcomes (ePROS) Market Report Segmentation Analysis

Key segments that contributed to the derivation of the electronic patient-reported outcomes (ePROS) market analysis are delivery mode, application, and end user.

• The electronic patient-reported outcomes (ePROS) market, based on delivery mode, is divided into cloud based and on-premise. The cloud based segment held a largest share of the market in 2023.
• By application, the market is segmented into oncology, respiratory, and others. The oncology segment held the largest share of the market in 2023.
• Based on end user, the electronic patient-reported outcomes (ePROS) market is segmented into CROs, pharmaceutical companies, and others. The pharmaceutical companies segment dominated the market in 2023.

Electronic Patient-Reported Outcomes (ePROS) Market Share Analysis by Geography

The geographic scope of the electronic patient-reported outcomes (ePROS) market report is mainly divided into five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the market in 2023. The market in this region is mainly driven by the presence of developed healthcare infrastructure, increased focus on digital health, and rise in product launches and other strategic initiatives by market players. The US is the largest and fastest-growing market for electronic patient-reported outcomes (ePROS). The country accounts for the major market share owing to the increasing use of digital health technologies, which helps provide patient-centered care. This involves integrating healthcare services with software and hardware, which can be managed and monitored with the help of apps, wearable devices, and other devices. The increasing focus on chronic disease management has increased the demand for ePROs as they allow continuous assessment and timely interventions. As per the article published by the American Society of Clinical Oncology in June 2023, in the US, ePRO inclusion in the Centers for Medicare and Medicaid Innovation's alternative payment model pilot, the Enhancing Oncology Model, is a sign that ePRO implementation should be a crucial step toward high-quality and transformational cancer care that is likely to foster broader adoption. The surging number of clinical trials in the country is expected to increase the demand for ePROs during the forecast period.

Electronic Patient-Reported Outcomes (ePROS) Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Electronic Patient-Reported Outcomes (ePROS) Market News and Recent Developments

The electronic patient-reported outcomes (ePROS) market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

• Clinical Ink launched EDCXtra—an innovative Electronic Data Capture (EDC) system. EDCXtra incorporates all existing DDC functionality into a single web-based application, which includes Clinical ink’s industry-leading electronic Clinical Outcome Assessments (eCOAs) and eConsent solutions. This application provides a comprehensive, all-in-one GCP-compliant platform. (Source: Clinical Ink, Company Website, August 2024)
• PatientIQ launched ResearchPRO an electronic data capture (EDC) platform designed to streamline the process of launching and managing research studies. With the introduction of ResearchPRO, PatientIQ is able to provide a more dedicated and sophisticated solution set tailored specifically to the unique needs of clinical researchers, clinical research organizations (CROs), and industry sponsors. (Source: PatientIQ, Company Website, July 2024)

Electronic Patient-Reported Outcomes (ePROS) Market Report Coverage and Deliverables

The "Electronic Patient-Reported Outcomes (ePROS) Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Electronic patient-reported outcomes (ePROS) market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Electronic patient-reported outcomes (ePROS) market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Electronic patient-reported outcomes (ePROS) market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the electronic patient-reported outcomes (ePROS) market
• Detailed company profiles